Every material Form 8-K NRC HEALTH has filed with the SEC since August 11, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
NRC Health reported third-quarter 2026 revenue of $38.4 million, up 11% from $34.6 million a year earlier, and diluted EPS of $0.21 versus $0.18. Adjusted EBITDA was $10.9 million, roughly flat year over year, and its margin fell to 28% from 31%. Nine-month net income fell to $4.6 million from $9.8 million, and the company declared a $0.16 quarterly dividend.
Q3 2026 revenue $38.4 million, up 11% from $34.6 million; TRCV $154.1 million, up 9%
Q3 2026 net income $4.7 million and diluted EPS $0.21, versus $4.1 million and $0.18 in Q3 2025
Nine-month 2026 net income $4.6 million versus $9.8 million, with diluted EPS $0.20 versus $0.43
Quarterly dividend of $0.16 per share, payable January 8, 2027, to holders of record December 29, 2026
NRC Health's board of directors on October 14, 2026 designated Chief Executive Officer Trent Green to also serve as interim principal financial officer. The filing says no compensation changes were made in connection with the appointment, so the change adds a role rather than replacing an executive.
Designation made by the board of directors on October 14, 2026
Trent Green has served as CEO since June 2025 and is 54 years old
No compensation changes tied to the interim finance role, per the filing
Filing states no arrangements or understandings with other persons for the appointment
NRC Health's Chief Financial Officer, Shane Harrison, resigned on August 7, 2026 to pursue an outside professional opportunity, effective August 28, 2026. The company has started a search for a new CFO, so shareholders will see a change in the officer who leads financial reporting.
Shane Harrison, Chief Financial Officer and principal financial officer, tendered his resignation on August 7, 2026.
Resignation is effective August 28, 2026.
Reason given: to pursue an outside professional opportunity.
The company has initiated a search for a new Chief Financial Officer.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every NRC HEALTH filing is on SEC EDGAR ↗. 8-K briefs of other companies →